CU6 (CU6) - Stock Discussion | I3investor

Clarity Pharmaceuticals Ltd

ASX (AUD): Clarity Pharmaceuticals Ltd (CU6)

Last Price

7.14

Today's Change

-0.32 (4.28%)

Day's Change

7.11 - 7.68

Trading Volume

586,758

Discussions

Be the first to like this. Showing 0 of 0 comments

Post a Comment

Latest Videos

MQ Market Updates - 11 November 2024

MQ Trader

Apps

Send individual or group chats with anyone on i3investor

Earn MQ Points while trading with MQ Trader

MQ Affiliate

Earn side income from Affiliate Program

Online learning and teaching marketplace

Top Articles

1

CEO Morning Brief

Australia Faces Economic Pain From Trump Win, Treasurer Warns

2

CEO Morning Brief

Australia to Ban Social Media for Children Under Age 16

Hot Stocks Today >

1

Lynas Rare Earths Limited

1000

2

Corporate Travel Management Limited

500

3

500

4

Domino's Pizza Enterprises Limited

500

5

Bank of Queensland Limited

500

6

Incitec Pivot Limited

500

7

Macmahon Holdings Limited

500

8

Nick Scali Limited

500

9

Transurban Group

500

10

500

Daily Stocks

0.001

0.00

128,012,960

0.019

+0.003

80,960,407

0.007

+0.001

64,163,240

0.018

+0.005

45,701,987

0.003

0.00

34,795,001

0.015

+0.003

28,360,002

0.29

+0.01

14,723,553

0.20

0.00

14,616,455

0.031

+0.004

14,124,503

0.049

-0.007

13,270,730

More active Stocks

131.02

+4.62

412,879

53.76

+3.52

1,966,660

66.52

+1.59

524,816

110.55

+1.44

5,924

36.91

+0.96

45,740

27.07

+0.78

244,744

11.62

+0.67

470,635

26.28

+0.57

204,206

90.31

+0.54

18,191

161.59

+0.45

121,149

More gainer Stocks

227.37

-3.83

173,036

62.56

-3.43

29,565

114.26

-3.275

904,173

283.49

-3.17

133,639

296.40

-3.01

36,441

190.40

-2.59

10,578

240.00

-2.16

35,685

35.54

-2.12

1,736,075

87.20

-2.06

1,945

105.44

-1.92

6,897

More loser Stocks

Top Brokers >

Books Review >

Ride The Bull Short The Bear

CS Tan

4.9 / 5.0

This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....